Moreover, the 36-month beta value for GMDA is 1.32. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The average price recommended by analysts for Gamida Cell Ltd (GMDA) is $4.00, which is $3.69 above the current market price. The public float for GMDA is 112.67M and currently, short sellers hold a 6.52% of that float. On November 20, 2023, GMDA’s average trading volume was 1.14M shares.
GMDA) stock’s latest price update
Gamida Cell Ltd (NASDAQ: GMDA) has seen a decline in its stock price by -4.00 in relation to its previous close of 0.32. However, the company has experienced a -48.45% decline in its stock price over the last five trading sessions. Market Watch reported 2023-10-09 that Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas’ attack on Israel.
GMDA’s Market Performance
Gamida Cell Ltd (GMDA) has experienced a -48.45% fall in stock performance for the past week, with a -63.68% drop in the past month, and a -75.02% drop in the past quarter. The volatility ratio for the week is 31.11%, and the volatility levels for the past 30 days are at 15.05% for GMDA. The simple moving average for the past 20 days is -54.34% for GMDA’s stock, with a -77.41% simple moving average for the past 200 days.
Analysts’ Opinion of GMDA
Many brokerage firms have already submitted their reports for GMDA stocks, with Alliance Global Partners repeating the rating for GMDA by listing it as a “Buy.” The predicted price for GMDA in the upcoming period, according to Alliance Global Partners is $11 based on the research report published on November 01, 2021 of the previous year 2021.
GMDA Trading at -64.28% from the 50-Day Moving Average
After a stumble in the market that brought GMDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.76% of loss for the given period.
Volatility was left at 15.05%, however, over the last 30 days, the volatility rate increased by 31.11%, as shares sank -61.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -75.22% lower at present.
During the last 5 trading sessions, GMDA fell by -48.45%, which changed the moving average for the period of 200-days by -81.60% in comparison to the 20-day moving average, which settled at $0.6482. In addition, Gamida Cell Ltd saw -76.18% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for GMDA
The total capital return value is set at -68.30, while invested capital returns managed to touch -74.10. Equity return is now at value -1103.79, with -66.32 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 118.97, with the company’s debt to enterprise value settled at 0.85. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.68.
To wrap up, the performance of Gamida Cell Ltd (GMDA) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.